Insufficient Data
Stock has not been able to generate better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Too much promoter holding pledged
—
—
—
Nectar Lifesciences Limited is a pharmaceutical company. The Company's operations include manufacturing and marketing of oral and sterile cephalosporin's, phytochemicals and allied products.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
A significant proportion of promoter holdings is pledged
In last 3 months, mutual fund holding of the company has almost stayed constant
Nectar Lifesciences Limited has informed the Exchange about resignation of Guljit Sethi as Independent Director of the company w.e.f. 09-May-2022. The relevant disclosures are attached herewith. | Download
Nectar Lifesciences Limited has informed the Exchange about resignation of Guljit Sethi as Independent Director of the company w.e.f. 09-May-2022. The relevant disclosures are attached herewith. | Download
Nectar Lifesciences Limited has informed the Exchange about resignation of Vivek Sett as Non Executive - Non Independent Director (Nominee Director) of the company w.e.f. 06-May-2022 | Download
Nectar Lifesciences Limited has informed the Exchange about resignation of Vivek Sett as Non Executive - Non Independent Director (Nominee Director) of the company w.e.f. 06-May-2022 | Download
Final • Div/Share: ₹ 0.05
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data